Concurrent Dual Biologic Therapy (Infliximab-Risankizumab and Dupilumab-Rituximab) for Complex Treatment-Refractory Dermatologic Disease: A Two-Patient Case Report.
The online reader was unable to display this document directly. This may occur if the repository host is temporarily unreachable, or if security restrictions (CORS) prevent embedded viewing.